Early abortion in Ontario: options and costs.
Limacher
J J
JJ
Department of Health Policy, Management and Evaluation, University of Toronto, Toronto ON; Department of Family and Community Medicine, University of Toronto, Toronto ON.
Daniel
I
I
Department of Health Policy, Management and Evaluation, University of Toronto, Toronto ON; Department of Family and Community Medicine, University of Toronto, Toronto ON.
Isaacksz
S
S
Department of Health Policy, Management and Evaluation, University of Toronto, Toronto ON; Department of Family and Community Medicine, University of Toronto, Toronto ON.
Payne
G J
GJ
Department of Health Policy, Management and Evaluation, University of Toronto, Toronto ON; Department of Family and Community Medicine, University of Toronto, Toronto ON.
Dunn
S
S
Department of Health Policy, Management and Evaluation, University of Toronto, Toronto ON; Department of Family and Community Medicine, University of Toronto, Toronto ON.
Coyte
P C
PC
Department of Health Policy, Management and Evaluation, University of Toronto, Toronto ON; Department of Family and Community Medicine, University of Toronto, Toronto ON.
Laporte
A
A
Department of Health Policy, Management and Evaluation, University of Toronto, Toronto ON; Department of Family and Community Medicine, University of Toronto, Toronto ON.
D000021:Abortifacient Agents, Steroidal / Q000627:therapeutic use*; D000028:Abortion, Induced / Q000191:economics* / Q000379:methods*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D005865:Gestational Age; D006801:Humans; D015735:Mifepristone / Q000627:therapeutic use; D016595:Misoprostol / Q000627:therapeutic use; D009864:Ontario; D011247:Pregnancy; D016896:Treatment Outcome
D000021:Abortifacient Agents, Steroidal; D016595:Misoprostol; D015735:Mifepristone